BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36561231)

  • 1. Negative correlation between the nuclear size and nuclear Lamina component Lamin A in intraductal papillary mucinous neoplasms of the pancreas.
    Hiroe T; Moriya S; Kobayashi S; Nishijima Y; Watanabe A; Shirabe K; Ikota H; Yokoo H; Saio M
    Pathol Oncol Res; 2022; 28():1610684. PubMed ID: 36561231
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas.
    Tajiri T; Tate G; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohosh T
    Pancreas; 2004 Aug; 29(2):116-22. PubMed ID: 15257103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.
    Ikemoto T; Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S
    J Gastroenterol Hepatol; 2015 Jan; 30(1):217-22. PubMed ID: 25041344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal oncocytic papillary neoplasm of the pancreas: clinical and radiological features compared to those of intraductal papillary mucinous neoplasm.
    Nakaya M; Nakai Y; Takahashi M; Fukukura Y; Sato K; Kameda A; Tashiro Y; Kageyama S; Sofue K; Nakano T; Yoshimitsu K; Marugami N; Takeyama N; Tanaka M; Hasegawa K; Watadani T
    Abdom Radiol (NY); 2023 Aug; 48(8):2483-2493. PubMed ID: 37358603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.
    Ishida M; Egawa S; Kawaguchi K; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Katayose Y; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreatology; 2008; 8(6):577-82. PubMed ID: 18824881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
    Ishida M; Egawa S; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Furukawa T; Unno M
    J Hepatobiliary Pancreat Surg; 2007; 14(5):522-5. PubMed ID: 17909725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.
    Ohtsuki Y; Watanabe R; Kimura M; Nomura K; Maeda T; Kito K; Takeji M; Lee GH; Furihata M
    Med Mol Morphol; 2015 Jun; 48(2):85-91. PubMed ID: 24908068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm].
    Taniuchi K; Okabayashi T; Sakaguchi M; Iwata J
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(3):235-244. PubMed ID: 33692257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Aronsson L; Bengtsson A; Torén W; Andersson R; Ansari D
    Int J Surg; 2019 Nov; 71():91-99. PubMed ID: 31546033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Correlation of Helical Computed Tomography (CT) Features With Pathologic Findings.
    Xu W; Liu X; Zhang J; Yang L
    Acad Radiol; 2017 May; 24(5):609-614. PubMed ID: 28153575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.
    Inagaki Y; Seyama Y; Hasegawa K; Tang W; Kokudo N
    Drug Discov Ther; 2014 Aug; 8(4):173-7. PubMed ID: 25047009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.